112 related articles for article (PubMed ID: 7074558)
1. Combination chemotherapy for advanced endometrial cancer. An evaluation of three regimens.
Horton J; Elson P; Gordon P; Hahn R; Creech R
Cancer; 1982 Jun; 49(12):2441-5. PubMed ID: 7074558
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of advanced and recurrent endometrial carcinoma with cyclophosphamide, doxorubicin, 5-fluorouracil, and megestrol acetate.
Deppe G; Jacobs AJ; Bruckner H; Cohen CJ
Am J Obstet Gynecol; 1981 Jun; 140(3):313-6. PubMed ID: 7246635
[No Abstract] [Full Text] [Related]
3. Chemotherapeutic treatment of endometrial carcinoma.
Deppe G
Clin Obstet Gynecol; 1982 Mar; 25(1):93-9. PubMed ID: 7039908
[No Abstract] [Full Text] [Related]
4. Chemotherapy in the management of advanced or recurrent cervical and endometrial carcinoma.
Thigpen T; Vance RB; Balducci L; Blessing J
Cancer; 1981 Jul; 48(2 Suppl):658-65. PubMed ID: 7023669
[No Abstract] [Full Text] [Related]
5. Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
Calabresi F; Di Lauro L; Marolla P; Curcio CG; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi CM; Di Palma M
Semin Oncol; 1991 Apr; 18(2 Suppl 4):66-72. PubMed ID: 2031201
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
7. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
Lovecchio JL; Averette HE; Lichtinger M; Townsend PA; Girtanner RW; Fenton AN
Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin, adriamycin, etoposide, megestrol acetate versus melphalan, 5-fluorouracil, medroxyprogesterone acetate in the treatment of endometrial carcinoma.
Cornelison TL; Baker TR; Piver MS; Driscoll DL
Gynecol Oncol; 1995 Nov; 59(2):243-8. PubMed ID: 7590480
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of advanced breast cancer with 2 successive chemotherapeutic schedules].
Pérez JE; Machiavelli M; Romero A; Leone BA; Rabinovich MG; Arévalo E
Medicina (B Aires); 1982; 42(6 Pt 1):587-95. PubMed ID: 6897849
[No Abstract] [Full Text] [Related]
10. Randomized comparison of two combination chemotherapy regimens containing doxorubicin in patients with metastatic breast cancer: a Western Cancer Study Group trial.
Irwin LE; Chlebowski RT; Weiner JM; Reynolds R; Pugh RP; Ryden VM; Bateman JR
Cancer Treat Rep; 1980; 64(8-9):981-4. PubMed ID: 7004635
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
[No Abstract] [Full Text] [Related]
12. Trials of single-agent and combination chemotherapy for advanced cancer of the pancreas.
Horton J; Gelber RD; Engstrom P; Falkson G; Moertel C; Brodovsky H; Douglass H
Cancer Treat Rep; 1981; 65(1-2):65-8. PubMed ID: 6452948
[TBL] [Abstract][Full Text] [Related]
13. Advanced ovarian adenocarcinoma. A prospective clinical trial of melphalan (L-PAM) versus combination chemotherapy.
Young RC; Chabner BA; Hubbard SP; Fisher RI; Bender RA; Anderson T; Simon RM; Canellos GP; DeVita VT
N Engl J Med; 1978 Dec; 299(23):1261-6. PubMed ID: 101843
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of advanced endometrial cancer].
Okada H; Yamamoto T
Gan To Kagaku Ryoho; 1990 Sep; 17(9):1848-55. PubMed ID: 2144105
[TBL] [Abstract][Full Text] [Related]
15. [Results of hormone and chemotherapy of patients with cancer of the corpus uteri].
Ploch E
Nowotwory; 1985; 35(3):255-61. PubMed ID: 4088901
[No Abstract] [Full Text] [Related]
16. Doxorubicin, cyclophosphamide, and 5-fluorouracil in patients with carcinoma of the cervix or vagina.
Piver MS; Barlow JJ; Dunbar J
Cancer Treat Rep; 1980; 64(4-5):549-51. PubMed ID: 7000344
[TBL] [Abstract][Full Text] [Related]
17. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy in advanced carcinoma of the cervix.
Sorbe B; Frankendal B
Cancer; 1982 Nov; 50(10):2028-30. PubMed ID: 7127247
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of paclitaxel and carboplatin versus combination chemotherapy with fluorouracil, doxorubicin and cyclophosphamide as a neoadjuvant therapy in patients with inoperable breast cancer.
Akhtar MS; Kousar F; Masood M; Fatimi S; Kokab
J Coll Physicians Surg Pak; 2010 Nov; 20(11):748-52. PubMed ID: 21078249
[TBL] [Abstract][Full Text] [Related]
20. [Advanced epithelial cancers of the ovary: results of 4 chemotherapy protocols (110 cases)].
Israël L; Lepage E; Breau JL; Aguilera J
Bull Cancer; 1982; 69(5):426-33. PubMed ID: 6891902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
